|
Macular Edema, Cystoid
|
0.010 |
Biomarker
|
disease |
BEFREE |
Strong correlation was found between the vessel density in the perifoveal ICP and DCP and outer retinal thickness in RP patients with no history of cystoid macular edema.
|
30849344 |
2019 |
|
Aseptic Meningitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Measurement of cerebrospinal fluid ACE level in aseptic meningitis: diagnostic?
|
31451467 |
2019 |
|
Multiple Myeloma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This suggests possible association of <i>ACE</i> I/D gene polymorphism with MM.
|
30788288 |
2019 |
|
Myopathy
|
0.010 |
Biomarker
|
group |
BEFREE |
In the present study, we evaluated the potential of ACE-083 - a locally acting, follistatin-based fusion protein - as a novel therapeutic agent for focal or asymmetric myopathies.
|
31388039 |
2019 |
|
Avascular necrosis of bone
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
For severe genotypes, angiotensin-converting enzyme-inhibitor/angiotensin receptor blocker use (OR, 6.10; 95% CI, 2.03-18.29; P=0.001) and avascular necrosis (OR, 0.40; 95% CI, 0.16-0.97; P=0.04) were associated with baseline CKD.
|
30797615 |
2019 |
|
Disorder of the optic nerve
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Inclusion criteria were unilateral chronic optic neuropathy and a work-up including contrast-enhanced MRI brain and orbits, CBC, ESR, CRP, ANA, CMIA, and ACE.
|
30760894 |
2019 |
|
Pemphigus
|
0.010 |
Biomarker
|
disease |
BEFREE |
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review.
|
30238580 |
2019 |
|
Aspiration Pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Association between Angiotensin-Converting Enzyme Inhibitors and Post-Stroke Aspiration Pneumonia.
|
31635965 |
2019 |
|
Retinitis Pigmentosa
|
0.010 |
Biomarker
|
disease |
BEFREE |
PR-OCTA enables the detection of microvascular changes in the perifoveal regions of the ICP and DCP in RP, with relative sparing of the SVC.
|
30849344 |
2019 |
|
Scleritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Confirmatory studies of whether adjunctive ACE inhibitor or statin treatment truly can enhance scleritis remission (as suggested here) are needed.
|
30951689 |
2019 |
|
Dermatologic disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
We searched for the terms "calcium-channel blockers" or "angiotensin-converting enzyme inhibitors" or "angiotensin II receptors blockers" or "diuretics" or "beta blockers" AND "dermatological effects" or "skin disease".
|
31195782 |
2019 |
|
Syphilis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Routine screening blood work (ACE, ANA, CMIA) and MRI brain and orbits for chronic idiopathic unilateral optic neuropathy has low diagnostic yield, especially if clinical suspicion for syphilis, lupus, and sarcoidosis is low.
|
30760894 |
2019 |
|
Thyroid Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
We examined in this study the expression of ACE and ACE2 in thyroid tissues and their possible employment as biomarkers for thyroid cancer progression.
|
31847529 |
2019 |
|
Alcohol abuse
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
About 40 (21.2%) pregnant women were identified by the T-ACE as at-risk for problem drinking during pregnancy.
|
31805891 |
2019 |
|
Pleocytosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CSF studies demonstrated lymphocyte predominant pleocytosis with an elevated ACE level.
|
31451467 |
2019 |
|
Adhesions of iris
|
0.010 |
Biomarker
|
disease |
BEFREE |
An older age at diagnosis (p=0.004) and the presence of synechiae (p=0.02) were significantly related to an abnormal <sup>18</sup>F-FDG PET/CT, with a trend for an elevated ACE (p=0.0993).
|
30658987 |
2019 |
|
Follicular adenoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thyroid tissues including 14 goiters (G), 12 follicular adenomas (FA), 10 follicular thyroid carcinomas (FTC), 14 papillary thyroid carcinomas (PTC) and 11 undifferentiated thyroid carcinomas (UTC) were subjected to RT-PCR and protein analyses with primers or antibodies specific for ACE and ACE2, respectively.
|
31847529 |
2019 |
|
Follicular thyroid carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ACE2 was significantly increased in PTC in comparison to G, FA and UTC, and in FTC as compared to G. The ratio ACE/ACE2 decreased while ACE2/ACE increased with the differentiation grade of thyroid carcinoma.
|
31847529 |
2019 |
|
Caffeine related disorders
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Some common genes that are included in nutrition-based multigene test panels include CYP1A2 (rate of caffeine break down), MTHFR (folate usage), NOS3 (risk of elevated triglyceride levels related to omega-3 fat intake), and ACE (blood pressure response in related to sodium intake).
|
31254340 |
2019 |
|
Selenium deficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
The use of the I-ACE software in a 6-month, 4-session dietician-delivered lifestyle counseling intervention improved the efficiency of lifestyle education, compared with SLA, among low-SES, ethnic minority patients with T2DM.
|
31621640 |
2019 |
|
Papillary thyroid carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ACE2 was significantly increased in PTC in comparison to G, FA and UTC, and in FTC as compared to G. The ratio ACE/ACE2 decreased while ACE2/ACE increased with the differentiation grade of thyroid carcinoma.
|
31847529 |
2019 |
|
Liver mass
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
<b>Abbreviations</b>: Angiotensin-converting enzyme (ACE); Angiotensin converting enzyme inhibitors (ACEIs); Angiotensin II (ANG II); Analysis of variance (ANOVA); Angiotensin receptor blockers (ARBs); Blood Pressure (BP); Calcium Antagonists Calcium Channel Blockers (CCB); Chronic kidney diseases (CKD); Sodium carboxyl methyl cellulose (CMC-Na); Cardiac mass index (CMI); Cardiovascular diseases (CVD); Diastolic blood pressure (DBP); Enzyme-linked immunosorbent assay (ELISA); Hematoxylin-eosin (H&E); Kidney mass index (KMI); Liver mass index (LMI); Mean arterial blood pressure (MAP); Plasma renin concentration (PRC); Renin-angiotensin system (RAS); Rennin (REN); Systolic blood pressure (SBP); Student-Newman-Keuls q test (SNK-q test); Spontaneous hypertension rats (SHR); Valsartan asleep Administration (VSA); Valsartan awake Administration (VWA); Wistar-Kyoto (WKY); Mesor (M); Amplitude (A); Phase (φ).
|
31096810 |
2019 |
|
Ophiasis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Among cases, serum ACE activity was significantly higher in patients with more severe disease (P = 0.030), nonpatchy alopecia areata (alopecia universalis; ophiasis, patchy and ophiasis, diffuse) (P = 0.029), and with nail involvement (P = 0.027).
|
29582789 |
2019 |
|
Alopecia universalis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Among cases, serum ACE activity was significantly higher in patients with more severe disease (P = 0.030), nonpatchy alopecia areata (alopecia universalis; ophiasis, patchy and ophiasis, diffuse) (P = 0.029), and with nail involvement (P = 0.027).
|
29582789 |
2019 |
|
Chronic congestive heart failure
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The long-term benefits of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) on outcomes in patients with chronic congestive heart failure are well-known, making them one of the most widely prescribed medications.
|
31797310 |
2019 |